+
Site Tour

R. Dworakowski "It's an ideal valve to be used for patients who may require future coronary interventions"

Discover what M. Van Wely, W-K. Kim, S. Khogali, M. Ozkor and R. Dworakowski think about Navitor™ and future interventions

Related Videos

Now you've got Navitor.
Stable delivery.

Now you've got Navitor. Remarkable performance.

Transfemoral TAVI

TAVI Summit - Live case from Berlin

TAVI with Navitor Vision - Livecase

Navitor™: Voice of the Experts Federico de Marco

TAVI Summit 2023: Aortic stenosis

TAVI 2023: Younger patients

EuroPCR 2022: Mitral replacement

Narcisa's testimonial

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

EXPAND Study: Data overview

PCR LV 2021: Navitor™ Looking ahead

TriClip™ G4: Product overview

AVP III Case compendium

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - Cardiac imaging and morphology

Echo course mitral TEER – cases

TAVI Summit - Cardiac imaging and morphology

TAVI 2023: Younger patients

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline